Skip to content
Disclosery

Founders Fund V Management, LLC

Follow

13F filer, CIK 1697733, SAN FRANCISCO, CA

Founders Fund V Management, LLC reported $845,997 across 4 holdings for the quarter ended 2024-06-30, in a 13F-HR filed 2024-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-24-003984

Period
2024-06-30
Reported value
$846K
Holdings
4
Top 10 weight
100%
New
1
Sold out
1

Part of the filer group Founders Fund Growth II Management, LP

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NTBLQnew+117,924$74.3K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NVMIexited-117,924-$209K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001085146-24-003984, largest first. % of portfolio is the value over $845,997, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CYCLO THERAPEUTICS INCCYCLO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 480,708 shares; 2024Q2: 480,708 shares 480,708$610K72.16%0
RGTIRIGETTI COMPUTING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 88,621 shares; 2024Q2: 88,621 shares 88,621$94.8K11.21%0Timeline
NTBLQNOTABLE LABS LTD ORD SHSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 117,924 shares 117,924$74.3K8.78%newTimeline
UNITY BIOTECHNOLOGY INC COM…UNITY BIOTECHNOLOGY INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 49,172 shares; 2024Q2: 49,172 shares 49,172$66.4K7.85%0

Sold out in Q2 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
NVMINOVA LTD117,924$209Kshares

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-24-003984 base2024-08-14acceptance time not in the bulk data set